Image pharmaphorum Editor Healthcare Transforming healthcare through sustainable and resilient da... In the past two decades, global spending on health has doubled. Pharma Market Access Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate. Patients Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate. Digital New €300m Angelini Ventures fund combines venture creation a... As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovat Load more results
Healthcare Transforming healthcare through sustainable and resilient da... In the past two decades, global spending on health has doubled.
Pharma Market Access Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
Patients Access solutions: the missing link that prevents biopharma i... We live in unprecedented times, where innovation in biosciences continues to accelerate.
Digital New €300m Angelini Ventures fund combines venture creation a... As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovat
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.